Although these findings suggest that MARCKS expression may be linked to features of hormone receptor insensitivity and tumor biology, Kaplan–Meier survival analysis did not reveal a significant difference in overall survival between MARCKS high and low groups within HER2 positive patients. This evidence concerns the gene ERBB2 and neoplasm.